Xavier Montalban
Overview
Explore the profile of Xavier Montalban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
520
Citations
23081
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization
Carvajal R, Tur C, Borras-Bermejo B, Saylor D, Montalban X, Tintore M, et al.
Mult Scler
. 2025 Mar;
:13524585251318513.
PMID: 40071952
Background: Vaccination in patients with multiple sclerosis (PwMS) presents unique challenges. Disease-modifying therapies (DMTs) can increase infectious risks, though these are largely preventable through immunizations. However, DMTs can also reduce...
2.
Dominguez-Mozo M, Lopez-Mecandez D, Villar L, Costa-Frossard L, Villarrubia N, Aladro Y, et al.
Ann Clin Transl Neurol
. 2025 Mar;
PMID: 40033709
Objective: An alteration in the composition of the intestinal microbiota has been observed in patients with multiple sclerosis (pwMS) with respect to healthy controls (HC). Microorganism-derived metabolites such as short-chain...
3.
Wiendl H, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, et al.
Front Immunol
. 2025 Feb;
16:1512189.
PMID: 39963134
Background And Objectives: Cladribine tablets (CladT) represent an effective immune reconstitution therapy, administered in short treatment courses over two consecutive years. To better understand the amplitude of immune changes, we...
4.
Marignier R, Villacieros-Alvarez J, Espejo C, Arrambide G, Fissolo N, Gutierrez L, et al.
J Neurol Neurosurg Psychiatry
. 2025 Feb;
PMID: 39939136
Background: Serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) have emerged as important biomarkers in multiple sclerosis (MS) and aquaporin-4 seropositive neuromyelitis optica spectrum disorder (AQP4-NMOSD)....
5.
Marrodan M, Sao Aviles A, Rio J, Cobo-Calvo A, Fernandez V, Pappolla A, et al.
Mult Scler
. 2025 Feb;
:13524585251316471.
PMID: 39925147
Background: Predicting treatment response and disease progression in multiple sclerosis (MS) is challenging. Treatment Response Scoring Systems (TRSS) are potentially useful, but their utility in patients receiving high-efficacy therapies and...
6.
Vilaseca A, Arranz P, Llaurado A, Zabalza A, Fonseca E, Medina I, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(2):e200369.
PMID: 39908479
Background And Objectives: The optimal immunosuppressive treatment for autoimmune chronic intestinal pseudo-obstruction (CIPO) is unknown due to lack of clinical trials. Even less data exist on treatment recommendations for patients...
7.
Vilaseca A, Tintore M, Carbonell-Mirabent P, Rodriguez-Barranco M, Arevalo M, Arino H, et al.
Mult Scler
. 2025 Feb;
:13524585251314749.
PMID: 39907218
Background: It is essential to exclude alternative diagnoses to diagnose multiple sclerosis (MS). However, detailed descriptions of alternative diagnoses in patients with suspected MS presenting with clinically isolated syndrome (CIS)...
8.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, et al.
Neurology
. 2025 Feb;
104(4):e210305.
PMID: 39903901
Background And Objectives: Emerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is increasingly...
9.
Dema M, Eixarch H, Hervera A, Castillo M, Villar L, Montalban X, et al.
Aging Cell
. 2025 Feb;
:e14491.
PMID: 39894902
The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability accumulation. This...
10.
Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Aviles A, Arrambide G, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200370.
PMID: 39879564
Background And Objectives: Invasive procedures may delay the diagnostic process in multiple sclerosis (MS). We investigated the added value of serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP),...